GREY:XEBEQ - Post by User
Comment by
Gann999on Sep 12, 2022 7:26pm
104 Views
Post# 34958110
RE:Mispriced
RE:MispricedI like what you are saying it sounds lovely but I think that revenue consensus is too high given we haven't seen a follow-up Biostream order or any large orders for a while now.
LyChauncey wrote: So the consensus Revenue for 2023 is 278 million. With 25% GM we have 70 million gross profit. With the cost reduction we are seeing, I expect the total operating expense around 58 million. 12 million accounting net income expected 2023. The market cap is about 108 million. Forward PE of 9 while expected to grow rapidly as 20% topline growth will translate into huge bottom line growth because of the high operating leverage. 108 million market cap is not going to last long imo.